AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102. A total of 147 filers reported holding AEGERION PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $181,000 | -66.5% | 49,050 | -8.2% | 0.00% | – |
| Q4 2015 | $540,000 | -33.0% | 53,450 | -9.8% | 0.00% | -100.0% |
| Q3 2015 | $806,000 | -28.4% | 59,250 | -0.1% | 0.00% | 0.0% |
| Q2 2015 | $1,125,000 | -27.5% | 59,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $1,552,000 | +25.0% | 59,300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $1,242,000 | -37.2% | 59,300 | 0.0% | 0.00% | -50.0% |
| Q3 2014 | $1,979,000 | +4.0% | 59,300 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,903,000 | -30.4% | 59,300 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $2,735,000 | -92.8% | 59,300 | -88.9% | 0.00% | -94.1% |
| Q4 2013 | $37,763,000 | +622.3% | 532,179 | +772.4% | 0.03% | +580.0% |
| Q3 2013 | $5,228,000 | +35.9% | 61,000 | +0.4% | 0.01% | +25.0% |
| Q2 2013 | $3,847,000 | – | 60,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,637,455 | $42,852,000 | 9.04% |
| Broadfin Capital, LLC | 2,502,578 | $65,492,000 | 5.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 5,349,840 | $140,005,000 | 3.03% |
| HighVista Strategies LLC | 265,110 | $6,938,000 | 1.11% |
| Perceptive Advisors | 381,100 | $9,973,000 | 0.78% |
| Healthcare Value Capital, LLC | 25,000 | $654,000 | 0.71% |
| ADVENT INTERNATIONAL, L.P. | 347,001 | $9,081,000 | 0.70% |
| Birchview Capital, LP | 46,000 | $1,204,000 | 0.63% |
| NORTH TIDE CAPITAL, LLC | 300,000 | $7,851,000 | 0.59% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 2,323,633 | $60,809,000 | 0.35% |